Ameritas Investment Partners’s Zimmer Biomet ZBH Stock Holding History

Ameritas Investment Partners’s Portfolio ZBH Stock Details ZBH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$147K	Sell	1,704 -70	-4%	-$6.14K	﹤0.01%	1599
2026 Q1	$160K	Hold	1,774	–	–	﹤0.01%	1406
2025 Q4	$160K	Sell	1,774 -93	-5%	-$8.82K	﹤0.01%	1393
2025 Q3	$184K	Hold	1,867	–	–	0.01%	1287
2025 Q2	$170K	Sell	1,867 -73	-4%	-$7.06K	0.01%	1403
2025 Q1	$220K	Hold	1,940	–	–	0.01%	1214
2024 Q4	$205K	Sell	1,940 -123	-6%	-$13.2K	0.01%	1307
2024 Q3	$223K	Sell	2,063 -227	-10%	-$24.8K	0.01%	1245
2024 Q2	$249K	Buy	2,290 +30	+1%	+$3.54K	0.01%	1130
2024 Q1	$298K	Sell	2,260 -152	-6%	-$19K	0.01%	1033
2023 Q4	$294K	Hold	2,412	–	–	0.01%	1040
2023 Q3	$271K	Sell	2,412 -121	-5%	-$15.4K	0.01%	1003
2023 Q2	$369K	Hold	2,533	–	–	0.01%	862
2023 Q1	$327K	Hold	2,533	–	–	0.01%	886
2022 Q4	$319K	Sell	2,533 -132	-5%	-$15.3K	0.01%	905
2022 Q3	$278K	Hold	2,665	–	–	0.01%	909
2022 Q2	$279K	Hold	2,665	–	–	0.01%	917
2022 Q1	$341K	Sell	2,665 -298	-10%	-$35.9K	0.01%	916
2021 Q4	$365K	Hold	2,963	–	–	0.01%	906
2021 Q3	$421K	Hold	2,963	–	–	0.02%	845
2021 Q2	$463K	Hold	2,963	–	–	0.02%	818
2021 Q1	$461K	Sell	2,963 -174	-6%	-$27K	0.02%	805
2020 Q4	$469K	Sell	3,137 -247	-7%	-$34.9K	0.02%	784
2020 Q3	$447K	Hold	3,384	–	–	0.02%	748
2020 Q2	$392K	Sell	3,384 -182	-5%	-$21K	0.02%	778
2020 Q1	$350K	Buy	3,566 +31	+0.9%	+$4.06K	0.02%	730
2019 Q4	$514K	Sell	3,535 -119	-3%	-$16.4K	0.02%	744
2019 Q3	$487K	Hold	3,654	–	–	0.02%	753
2019 Q2	$418K	Sell	3,654 -158	-4%	-$18.5K	0.02%	778
2019 Q1	$473K	Hold	3,812	–	–	0.02%	746
2018 Q4	$384K	Hold	3,812	–	–	0.02%	759
2018 Q3	$487K	Sell	3,812 -171	-4%	-$20.3K	0.02%	737
2018 Q2	$431K	Sell	3,983 -330	-8%	-$35.9K	0.02%	764
2018 Q1	$457K	Sell	4,313 -284	-6%	-$33K	0.02%	764
2017 Q4	$539K	Sell	4,597 -168	-4%	-$19K	0.02%	728
2017 Q3	$528K	Hold	4,765	–	–	0.03%	734
2017 Q2	$594K	Sell	4,765 -2,281	-32%	-$270K	0.03%	712
2017 Q1	$835K	Sell	7,046 -345	-5%	-$39.1K	0.04%	580
2016 Q4	$740K	Sell	7,391 -2,571	-26%	-$276K	0.04%	631
2016 Q3	$1.26M	Sell	9,962 -16,814	-63%	-$2.08M	0.07%	372
2016 Q2	$3.13M	Sell	26,776 -1,817	-6%	-$206K	0.2%	100
2016 Q1	$2.96M	Buy	28,593 +4,944	+21%	+$478K	0.2%	104
2015 Q4	$2.35M	Hold	23,649	–	–	0.16%	139
2015 Q3	$2.16M	Buy	23,649 +1,133	+5%	+$114K	0.15%	150
2015 Q2	$2.39M	Buy	22,516 +19,049	+549%	+$2.11M	0.16%	151
2015 Q1	$395K	Hold	3,467	–	–	0.03%	706
2014 Q4	$381K	Buy	3,467 +278	+9%	+$29.3K	0.03%	727
2014 Q3	$311K	Sell	3,189 -189	-6%	-$18.6K	0.02%	786
2014 Q2	$341K	Sell	3,378 -138	-4%	-$13.5K	0.02%	777
2014 Q1	$323K	Sell	3,516 -171	-5%	-$15.8K	0.03%	767
2013 Q4	$334K	Hold	3,687	–	–	0.03%	766
2013 Q3	$294K	Buy	+3,687	New	+$290K	0.03%	756

Other funds holding ZBH

Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Harris Associates Chicago, Illinois $75.4B AUM 14.46% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Ameritas Investment Partners's ZBH Position: Q2 2026 in Review

Ameritas Investment Partners reduced its Zimmer Biomet (ZBH) stake by 3.9% in Q2 2026, selling an estimated $6.14K and leaving 1,704 shares worth $147K. The position accounts for ﹤0.01% of the portfolio, ranked #1599.

Ameritas Investment Partners first reported a position in ZBH in Q3 2013 and has held it in 52 quarters since. The position peaked at $3.13M in Q2 2016. 906 funds tracked by Wall St. Rank hold ZBH as of Q2 2026.

Ameritas Investment Partners held 1,704 shares of Zimmer Biomet worth $147K as of Q2 2026.
Ameritas Investment Partners sold 70 Zimmer Biomet shares in Q2 2026, an estimated $6.14K.
Zimmer Biomet made up ﹤0.01% of Ameritas Investment Partners's portfolio in Q2 2026, its #1599 holding.
Ameritas Investment Partners first reported a position in Zimmer Biomet in Q3 2013 and has held it in 52 quarters since.
Ameritas Investment Partners's Zimmer Biomet position peaked at $3.13M in Q2 2016.
906 funds tracked by Wall St. Rank held Zimmer Biomet as of Q2 2026.

Based on Ameritas Investment Partners's 13F filing for Q2 2026, filed 13 Aug 2026.